Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant

Rapid COVID-19 diagnosis in the hospital is essential, although this is complicated by 30%–50% of nose/throat swabs being negative by SARS-CoV-2 nucleic acid amplification testing (NAAT). Furthermore, the D614G spike mutant dominates the pandemic and it is unclear how serological tests designed to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Mlcochova, Petra, Collier, Dami, Ritchie, Allyson, Assennato, Sonny M., Hosmillo, Myra, Goel, Neha, Meng, Bo, Chatterjee, Krishna, Mendoza, Vivien, Temperton, Nigel, Kiss, Leo, James, Leo C., Ciazynska, Katarzyna A., Xiong, Xiaoli, Briggs, John A.G., Nathan, James A., Mescia, Federica, Bergamaschi, Laura, Zhang, Hongyi, Barmpounakis, Petros, Demeris, Nikos, Skells, Richard, Lyons, Paul A., Bradley, John, Baker, Steven, Allain, Jean Pierre, Smith, Kenneth G.C., Bousfield, Rachel, Wilson, Michael, Sparkes, Dominic, Amoroso, Glenn, Gkrania-Klotsas, Effrosyni, Hardwick, Susie, Boyle, Adrian, Goodfellow, Ian, Gupta, Ravindra K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462534/
https://www.ncbi.nlm.nih.gov/pubmed/32905045
http://dx.doi.org/10.1016/j.xcrm.2020.100099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462534/
https://www.ncbi.nlm.nih.gov/pubmed/32905045
http://dx.doi.org/10.1016/j.xcrm.2020.100099

Ejemplares similares